Star Combo Pharma Past Earnings Performance
Past criteria checks 3/6
Star Combo Pharma has been growing earnings at an average annual rate of 0.5%, while the Personal Products industry saw earnings growing at 8.5% annually. Revenues have been declining at an average rate of 7.2% per year. Star Combo Pharma's return on equity is 2.2%, and it has net margins of 2.9%.
Key information
0.5%
Earnings growth rate
4.1%
EPS growth rate
| Personal Products Industry Growth | -25.2% |
| Revenue growth rate | -7.2% |
| Return on equity | 2.2% |
| Net Margin | 2.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Some Star Combo Pharma Limited (ASX:S66) Shareholders Look For Exit As Shares Take 31% Pounding
Nov 11
Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up
Aug 23Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger
Aug 13Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 12Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price
May 12Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon
Mar 20Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?
Nov 21Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think
Mar 02Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt
Dec 24
Revenue & Expenses Breakdown
How Star Combo Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 26 | 1 | 5 | 0 |
| 31 Mar 24 | 26 | 1 | 5 | 0 |
| 31 Dec 23 | 25 | 0 | 4 | 0 |
| 30 Sep 23 | 25 | -2 | 4 | 0 |
| 30 Jun 23 | 25 | -4 | 4 | 0 |
| 31 Mar 23 | 24 | -5 | 4 | 0 |
| 31 Dec 22 | 23 | -5 | 4 | 0 |
| 30 Sep 22 | 23 | -3 | 4 | 0 |
| 30 Jun 22 | 23 | -1 | 5 | 0 |
| 31 Mar 22 | 24 | -5 | 5 | 0 |
| 31 Dec 21 | 24 | -8 | 5 | 0 |
| 30 Sep 21 | 26 | -8 | 5 | 0 |
| 30 Jun 21 | 27 | -8 | 5 | 0 |
| 31 Mar 21 | 30 | -3 | 5 | 0 |
| 31 Dec 20 | 33 | 1 | 5 | 0 |
| 30 Sep 20 | 36 | 1 | 6 | 0 |
| 30 Jun 20 | 39 | 0 | 6 | 0 |
| 31 Mar 20 | 38 | -1 | 6 | 0 |
| 31 Dec 19 | 37 | -2 | 6 | 0 |
| 30 Sep 19 | 29 | -2 | 6 | 0 |
| 30 Jun 19 | 22 | -2 | 6 | 0 |
| 31 Mar 19 | 17 | -2 | 7 | 0 |
| 31 Dec 18 | 12 | -3 | 8 | 0 |
| 30 Sep 18 | 12 | -2 | 7 | 0 |
| 30 Jun 18 | 11 | -2 | 6 | 0 |
| 30 Jun 17 | 10 | 2 | 2 | 0 |
| 30 Jun 16 | 9 | 2 | 1 | 0 |
| 30 Jun 15 | 7 | 0 | 0 | 0 |
| 30 Jun 14 | 5 | 0 | 0 | 0 |
Quality Earnings: S66 has high quality earnings.
Growing Profit Margin: S66 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: S66 has become profitable over the past 5 years, growing earnings by 0.5% per year.
Accelerating Growth: S66 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: S66 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (10.2%).
Return on Equity
High ROE: S66's Return on Equity (2.2%) is considered low.